Biogend Therapeutics Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020
November 09, 2020 at 11:41 pm IST
BioGend Therapeutics Co., Ltd. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 589,000 compared to TWD 364,000 a year ago. Operating loss was TWD 40.480 million compared to TWD 44.295 million a year ago. Net loss was TWD 44.266 million compared to TWD 40.026 million a year ago. Basic loss per share was TWD 0.48 compared to TWD 0.49 a year ago. For the nine months, sales was TWD 1.074 million compared to TWD 1.105 million a year ago. Operating loss was TWD 104.665 million compared to TWD 120.299 million a year ago. Net loss was TWD 114.379 million compared to TWD 114.260 million a year ago. Basic loss per share was TWD 1.33 compared to TWD 1.41 a year ago.